Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abbott Increases Biologics Capacity | Contract Pharma

What are you searching for?

Sign in
Breaking News

Abbott Increases Biologics Capacity

Launches disposable manufacturing suite

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott is expanding its contract bio-manufacturing capabilities. The company recently qualified and launched a manufacturing suite in Worcester, MA containing 2 x 500 L single-use bioreactors. According to the company, this additional early phase cGMP capacity capitalizes on disposable technologies to optimize production value in terms of process flexibility and efficient change over.

Abbott has also introduced a new chemically defined media, which, according to the company, has demonstrated titer improvements by as much as 30% compared to prior generation media compositions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics